StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX - Get Free Report) in a research report issued on Saturday. The brokerage set a "hold" rating on the stock.
Brooklyn ImmunoTherapeutics Stock Down 0.6 %
Brooklyn ImmunoTherapeutics stock traded down $0.04 during mid-day trading on Friday, reaching $6.68. 532,196 shares of the company's stock were exchanged, compared to its average volume of 816,227. The firm has a market capitalization of $392.96 million, a PE ratio of -2.94 and a beta of 4.61. The business's fifty day simple moving average is $3.38 and its 200 day simple moving average is $1.72. Brooklyn ImmunoTherapeutics has a one year low of $6.35 and a one year high of $8.31.
Brooklyn ImmunoTherapeutics Company Profile
(
Get Free Report)
Eterna Therapeutics, Inc is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B.
Read More
Before you consider Brooklyn ImmunoTherapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Brooklyn ImmunoTherapeutics wasn't on the list.
While Brooklyn ImmunoTherapeutics currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
